These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S. Int Immunol; 2002 Oct; 14(10):1225-31. PubMed ID: 12356687 [Abstract] [Full Text] [Related]
23. A20 is a negative regulator of IFN regulatory factor 3 signaling. Saitoh T, Yamamoto M, Miyagishi M, Taira K, Nakanishi M, Fujita T, Akira S, Yamamoto N, Yamaoka S. J Immunol; 2005 Feb 01; 174(3):1507-12. PubMed ID: 15661910 [Abstract] [Full Text] [Related]
25. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, Billiar TR. Infect Immun; 2002 Jul 01; 70(7):3433-42. PubMed ID: 12065483 [Abstract] [Full Text] [Related]
26. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. Sirén J, Pirhonen J, Julkunen I, Matikainen S. J Immunol; 2005 Feb 15; 174(4):1932-7. PubMed ID: 15699120 [Abstract] [Full Text] [Related]
32. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. Equils O, Faure E, Thomas L, Bulut Y, Trushin S, Arditi M. J Immunol; 2001 Feb 15; 166(4):2342-7. PubMed ID: 11160291 [Abstract] [Full Text] [Related]
34. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. Wietek C, Miggin SM, Jefferies CA, O'Neill LA. J Biol Chem; 2003 Dec 19; 278(51):50923-31. PubMed ID: 14557267 [Abstract] [Full Text] [Related]
36. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y. J Exp Med; 2010 Apr 12; 207(4):721-30. PubMed ID: 20231379 [Abstract] [Full Text] [Related]
37. TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus. Gomes MT, Campos PC, Pereira Gde S, Bartholomeu DC, Splitter G, Oliveira SC. J Leukoc Biol; 2016 May 12; 99(5):771-80. PubMed ID: 26578650 [Abstract] [Full Text] [Related]
38. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A, Maliszewski C, Akira S, Pulendran B. J Immunol; 2004 Apr 15; 172(8):4733-43. PubMed ID: 15067049 [Abstract] [Full Text] [Related]
39. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. François S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA, Elbim C. J Immunol; 2005 Mar 15; 174(6):3633-42. PubMed ID: 15749901 [Abstract] [Full Text] [Related]
40. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. Osterlund P, Veckman V, Sirén J, Klucher KM, Hiscott J, Matikainen S, Julkunen I. J Virol; 2005 Aug 15; 79(15):9608-17. PubMed ID: 16014923 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]